{
    "nctId": "NCT05046301",
    "briefTitle": "Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications",
    "officialTitle": "Contrast-Enhanced Mammography (CEM) and CEM-Directed Biopsy for the Evaluation of Extensive Suspicious Mammographic Microcalcifications",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 151,
    "primaryOutcomeMeasure": "Accuracy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with suspicious mammographic microcalcifications (Breast Imaging Reporting and Data System \\[BI-RADS\\] categories 4 or 5) occupying an area equal to or exceeding 4 cm in diameter and recommended for a stereotactic biopsy, who underwent their diagnostic imaging work-up resulting in a biopsy recommendation at MD Anderson Cancer Center (MDACC) or at an outside facility with a technically acceptable quality of diagnostic mammography, and who are planning to have their stereotactic biopsy at MDACC.\n* Age 25-85 years\n* Willing to participate in the study, undergo an intravenous (IV) placement, able to undergo iodinated contrast injection, and able to provide informed consent\n\nExclusion Criteria:\n\n* Reported history of an allergic reaction to iodinated contrast\n* History of anaphylactic reaction to any substance that required hospitalization or IV placement in a patient with no known prior uneventful exposure to iodine-based IV contrast\n* Renal insufficiency\n* Pregnancy or lactation within 6 months\n* Breast surgery affecting the site of interest within prior 6 months\n* Breast biopsy at the site of interest within the last 2 months\n* Mammographic mass or architectural distortion associated with the calcifications in question",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}